Never Miss a Potential Recovery Again

Sign up for Class
Action Alerts

Each year, class action lawsuits generate billions of dollars in settlement funds, but many shareholders fail to file a claim. Stay in the know regarding class action lawsuits by signing up for alerts.

Levi & Korsinsky, LLP does not share your information with others. There is no cost or obligation for you to submit. No spam will be sent to your email.

We Give Shareholders A Voice.

The market fluctuates, but we don’t. We give you straight answers from real attorneys who have spent decades helping shareholders protect their investments and recover their losses.

Settlements

$14 Million

Corcept Therapeutics Incorporated

$9.5 Million

Babcock & Wilcox Enterprises, Inc.

$40 Million

U.S. Steel

$7 Million

Aqua Metals, Inc.

$7.025 Million

WideOpenWest, Inc.

$8.25 Million

Helios and Matheson Analytics Inc.

$13.85 Million

Illumina, Inc.

$14.5 Million

Avon Products Inc.

I think you’ve done a superb job and I really appreciate the way this case was handled.

The Honorable Ronald B. Rubin in Teoh v. Ferrantino, C.A. No. 356627 (Cir. Ct. for Montgomery Cnty., MD 2012)

…a model for how [the] great legal profession should conduct itself.

Justice Timothy S. Driscoll in Grossman v. State Bancorp, Inc., Index No. 600469/2011 (N.Y. Sup. Ct. Nassau Cnty. Nov. 29, 2011)

I find the firm to be well-qualified to serve as Lead Counsel.

The Honorable Andrew L. Carter, Jr. In Snyder v. Baozun Inc., No. 1:19-CV-11290 (S.D.N.Y. Sept. 8, 2020)

In appointing the Firm Lead Counsel, the Honorable Analisa Torres noted our “extensive experience” in securities litigation.

White Pine Invs. v. CVR Ref., LP, No. 20 CIV. 2863 (S.D.N.Y. Jan. 5, 2021)

Class Counsel have demonstrated that they are skilled in this area of the law and therefore adequate to represent the Settlement Class as well.

Furthermore, with the increasing importance of compliance and risk management, kyc for law firms has become an essential component of legal services.

The Honorable Barry Ted Moskowitz in In re Regulus Therapeutics Inc. Sec. Litig., No. 3:17-CV-182-BTM-RBB (S.D. Cal. Oct. 30, 2020)

Who We Are

We combine specialized securities expertise with an innovative approach to litigation and an enduring commitment to our clients. We represent individuals, institutions, and asset managers in some of the largest, most complex securities cases in the country and never shy away from an uphill battle.

Online casinos that accept a minimum deposit of $10 are a great option for players who want to try out their luck without risking too much money. These 10 dollar deposit casinos offer a variety of games, including slots, table games, and live dealer games, as well as various payment options to make depositing and withdrawing funds easy.

Nos últimos anos, os casinos online tornaram-se extremamente populares, e um número crescente de jogadores está a optar por fazê-lo a partir do conforto das suas próprias casas. Um dos métodos de pagamento mais bem aceites pelos casinos online é o PayPal, uma carteira digital que permite aos utilizadores depositar e receber dinheiro de forma simples e segura. Os casinos PayPal são estabelecimentos de jogo online que aceitam PayPal como forma de pagamento.
A popularidade do PayPal como método de pagamento de casino online pode ser atribuída tanto à sua usabilidade como às suas características de segurança. Quando utiliza o PayPal para fazer um depósito ou levantamento num casino, não precisa de dar ao casino acesso aos seus dados financeiros pessoais. Apenas precisa do seu endereço de e-mail e palavra-passe PayPal para completar a transacção. Isto reduz significativamente a probabilidade de fraude e roubo de identidade. Além disso, as transacções PayPal são processadas rapidamente, permitindo-lhe começar quase imediatamente a jogar os jogos de casino que escolheu.

Mi is a status company working with securities and innovative approaches with online casino gamblers. We provide you with an open door to our offices where online casino players can view a win palace review. Our company, together with online casinos, works in more than 40 courts throughout the country and is considered the best company.

O facto de o PayPal ser amplamente reconhecido é um benefício adicional da sua utilização num casino online pagamento Paypal. Porque o PayPal é um método de pagamento fiável e bem respeitado, vários casinos online decidiram incluí-lo na sua lista de métodos de pagamento aprovados. Tem agora opções adicionais para jogar porque uma variedade de casinos em linha aceita PayPal para depósitos e levantamentos.
Um casino PayPal é um casino online que aceita PayPal como uma forma de pagamento. Ao optar por financiar as suas contas em casinos online com PayPal, os jogadores têm uma opção segura, segura e útil. Dada a sua conveniência, características de segurança, e aceitação geral, faz sentido que o PayPal se tenha tornado um dos métodos de pagamento mais frequentemente utilizados para casinos online. Se procura um método de pagamento fiável e de confiança para as suas actividades de jogo online, pense em utilizar PayPal num casino que aceite PayPal.

In the fast-paced world of online casinos, one of the most critical elements to ensuring that their business is legally compliant is working with the best lawyers. The legal landscape around online gambling is complex and constantly evolving, making it essential for online casinos to have legal experts on hand to help navigate this tricky terrain. In this article, we will explore how online casinos cooperate with the best lawyers and why this is essential to their success. Firstly, working with the best lawyers can help online casinos https://casinosworld.ca/best-payout-online-casinos/ ensure that they are operating within the confines of the law. Online gambling regulations can vary significantly from jurisdiction to jurisdiction, and it can be challenging for online casinos to stay on top of the latest changes. By working with experienced lawyers who specialize in gambling law, online casinos can be confident that they are always up to date with the latest legal developments and that their business is fully compliant.

Ice hockey is one of the most exciting and dynamic sports in the world, and it’s no surprise that many people enjoy betting on it. However, one group of professionals that has taken a particular interest in hockey betting is lawyers and attorneys. In this article, we will explore why hockey betting is popular among lawyers and attorneys and what they enjoy about this unique form of gambling. One reason that lawyers and attorneys enjoy hockey betting is that it requires a deep understanding of the game and its rules. As legal professionals, they are trained to analyze complex information and make informed decisions based on that information. This analytical approach is well-suited to sports betting, where successful bettors must understand the intricacies of the game and make informed decisions based on those details. Hockey betting provides a unique challenge that many lawyers and attorneys find appealing. Another reason that hockey betting https://thewincolumn.ca/2023/02/11/sports-betting-101-how-to-bet-on-hockey/ is popular among lawyers and attorneys is that it allows them to stay up to date with the latest legal developments in the sports world. As legal professionals, they are always looking for new opportunities to expand their knowledge and expertise. By betting on hockey, they can stay up to date with the latest developments in the sport, including any changes to the rules or regulations that may affect betting odds.

1
1
1
1
1
1

We're here for you

Find an Attorney

Required Field

Coin Image

Don't hesitate

Find a Case

Upcoming Deadlines

Investors interested in taking an active role in litigation have a limited time to petition the court for appointment as lead plaintiff. If you are interested in acting as a lead plaintiff, submit your transactions before the deadline, and our analysts will calculate your losses. Don't wait till the last minute- discuss your options today.
View All Deadlines

Due

Today

BIVI

BioVie Inc.

Deadline

March 19 2024

Class Period

8/5/21 - 11/29/23

Allegations

(1) BioVie was not conducting proper oversight of its Phase 3 clinical trial; (2) the COVID-19 pandemic significantly and negatively impacted the Company's ability to adequately conduct proper oversight of the Phase 3 clinical trial; (3) due to lack of proper oversight and reliance on contract research organizations, the data from defendants' Phase 3 clinical trial faced a greater risk of being unreliable and that the majority of patients would have to be excluded from the clinical trial; (4) as a result of the significant exclusions from the trial results, the Phase 3 clinical trial would fail to meet its primary endpoints; and (5) statements about BioVie's business, operations, prospects, and compliance with current good clinical practices were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Class Period

8/5/21 - 11/29/23

Deadline

March 19 2024

Learn More

Due

Today

ALVR

AlloVir, Inc.

Deadline

March 19 2024

Class Period

3/22/22 - 12/21/23

Allegations

(i) the posoleucel Phase 3 Studies were unlikely to meet their primary endpoints; (ii) as a result, it was likely that the Company would ultimately discontinue the posoleucel Phase 3 studies; (iii) accordingly, AlloVir overstated the efficacy and clinical and/or commercial prospects of posoleucel; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

3/22/22 - 12/21/23

Deadline

March 19 2024

Learn More

6

Days Left

BTI

British American Tobacco p.l.c.

Deadline

March 25 2024

Class Period

2/9/23 - 12/6/23

Allegations

(1) British American Tobacco materially understated the risks and potential likelihood of an impairment to its Premium American Cigarette Brands as a result of various longstanding headwinds and; (2) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Class Period

2/9/23 - 12/6/23

Deadline

March 25 2024

Learn More

6

Days Left

EVVTY

Evolution AB (publ)

Deadline

March 25 2024

Class Period

2/14/19 - 10/25/23

Allegations

(1) in “allowing play” from certain jurisdictions, multiple customers of Evolution AB’s were, or were deemed by regulators to be, unlicensed and/or in breach of the laws of those jurisdictions; and (2) defendants’ statements were false, as they misrepresented the extent of Evolution AB’s involvement with regulatorily noncompliant customers. When the true details entered the market, the lawsuit claims that investors suffered damages.

Class Period

2/14/19 - 10/25/23

Deadline

March 25 2024

Learn More

6

Days Left

ADM

Archer-Daniels-Midland Company

Deadline

March 25 2024

Class Period

4/30/20 - 1/22/24

Allegations

According to the filed complaint, defendants made false and/or misleading statements and/or failed to disclose material facts about the performance and prospects of ADM’s Nutrition segment and its accounting practices. Specifically, defendants made positive statements about the Nutrition segment as a future profit-driver for the Company, with the ability to capitalize on healthier eating trends and rising consumer demand for natural ingredients and flavoring. Defendants also created the impression that the Nutrition segment’s growth would provide more diversification and earnings stability for ADM.

Class Period

4/30/20 - 1/22/24

Deadline

March 25 2024

Learn More

6

Days Left

RILY

B. Riley Financial, Inc.

Deadline

March 25 2024

Class Period

5/10/23 - 11/9/23

Allegations

(1) Brian Kahn, a client of the Company, had been credibly implicated in a conspiracy to defraud investors of millions of dollars; (2) in spite of this involvement, B. Riley continued to finance the transaction enabling Kahn and others to take Franchise Group, Inc. private through complex arrangements; (3) the foregoing was reasonably likely to draw regulatory scrutiny to B. Riley; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

5/10/23 - 11/9/23

Deadline

March 25 2024

Learn More

6

Days Left

CART

Maplebear Inc. d/b/a Instacart

Deadline

March 25 2024

Class Period

This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Instacart common stock pursuant and/or traceable to offering documents issued in connection with the Company’s initial public offering conducted on or about September 19, 2023; and/or (b) Instacart securities between September 19, 2023 and October 1, 2023, both dates inclusive.

Allegations

(i) Instacart had overstated the extent to which online grocery shopping and delivery habits among consumers were accelerating; (ii) Instacart had downplayed the extent of the competition that it faced in the online grocery shopping and delivery market; (iii) accordingly, defendants overstated the Company’s post-initial public offering growth, business, and financial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Instacart common stock pursuant and/or traceable to offering documents issued in connection with the Company’s initial public offering conducted on or about September 19, 2023; and/or (b) Instacart securities between September 19, 2023 and October 1, 2023, both dates inclusive.

Deadline

March 25 2024

Learn More

6

Days Left

EAF

GrafTech International Ltd.

Deadline

March 25 2024

Class Period

2/8/19 - 8/3/23

Allegations

(a) GrafTech’s manufacturing operations in Monterrey, Mexico had for decades chronically contaminated neighboring communities with harmful carcinogenic gasses and particulate matter; (b) GrafTech had signed agreements with local authorities committing itself to improving the environmental performance of its Monterrey facility, but repeatedly failed to honor these commitments; (c) GrafTech had been repeatedly warned over an approximately 30-year period regarding its wanton disregard for the environment and health and well-being of people near its operations in Monterrey, Mexico; (d) GrafTech’s operations in Monterrey, Mexico were not in compliance with applicable environmental laws and regulations; (e) the Company had failed to adequately remediate the environmental problems caused by the Monterrey facility following the 2019 administrative proceeding conducted by the Department of Sustainable Development of the State of Nuevo León; (f) the government of Apodaca had sought intervention from the State of Nuevo León authorities to curtail and prevent the adverse environmental impacts and noncompliance with environmental laws and regulations caused by the Monterrey facility; (g) GrafTech’s purported cost leadership was achieved in substantial part by failing to implement appropriate and effective environmental safeguards at its manufacturing facility in Monterrey, Mexico; (h) GrafTech’s capital expenditures and/or related operational projects were woefully insufficient to adequately address the harm that the Company’s operations in Monterrey, Mexico had inflicted on the environment and people within the neighboring communities; (i) as a result of (a)-(h), GrafTech was acutely exposed to undisclosed material risks that the Company’s manufacturing operations in Monterrey, Mexico would be severely disrupted by government action or enforcement; and (j) as a result of (a)-(i), GrafTech was acutely exposed to undisclosed material risks that its supplies of pin stock and graphite electrodes would be withdrawn and/or materially diminished, thereby materially harming the Company’s business, operations, reputation, and financial results.

Class Period

2/8/19 - 8/3/23

Deadline

March 25 2024

Learn More

14

Days Left

SAVA

Cassava Sciences, Inc.

Deadline

April 2 2024

Class Period

8/18/22 - 10/12/23

Allegations

(i) the Company failed to maintain adequate and effective data management controls and procedures related to its drug research programs; (ii) as a result, the data published in support of the Company’s lead therapeutic drug candidate, PTI-125 (or “simufilam”), were susceptible to manipulation to overstate the drug’s effectiveness; (iii) accordingly, Cassava had misrepresented the efficacy of its research programs and the clinical and/or commercial prospects of simufilam; (iv) all of the foregoing, once revealed, was likely to subject the Company to significant financial and/or reputational harm; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

8/18/22 - 10/12/23

Deadline

April 2 2024

Learn More

20

Days Left

IRTC

iRhythm Technologies, Inc.

Deadline

April 8 2024

Class Period

1/11/22 - 5/30/23

Allegations

According to the lawsuit, defendants falsely represented to investors that one of iRhythm’s main products, the Zio AT monitor, was a real-time heart monitor intended for high-risk patients. Specifically, defendants repeatedly touted the potential growth for the Zio AT as an innovative product that had only just begun to penetrate the market for real-time monitoring, which investors looked upon favorably given the premium selling price associated with devices approved for high-risk patients. As a result of these misrepresentations, the price of iRhythm common stock traded at artificially inflated prices throughout the class period.

Class Period

1/11/22 - 5/30/23

Deadline

April 8 2024

Learn More

20

Days Left

NYCB

New York Community Bancorp, Inc.

Deadline

April 8 2024

Class Period

3/1/23 - 1/30/24

Allegations

(1) the Company was experiencing higher net charge-offs and deterioration in its office portfolio; (2) as a result, NYCB was reasonably likely to incur higher loan losses; (3) as a result of the foregoing and NYCB’s status as Category IV bank, the Company was reasonably likely to increase its allowance for credit losses; (4) the Company’s financial results would be adversely affected; (5) to preserve capital, the Company would reduce quarterly common dividend to $0.05 per common share; and (6) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

3/1/23 - 1/30/24

Deadline

April 8 2024

Learn More

20

Days Left

HUT

Hut 8 Corp.

Deadline

April 8 2024

Class Period

11/9/23 - 1/18/24

Allegations

(1) one of the largest shareholders in U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”), one of the companies that merged to create Hub 8, is an undisclosed related party; (2) one of USBTC’s core assets has historically failed to provide energy and high-speed internet; (3) the profitability of certain USBTC assets were overstated; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

11/9/23 - 1/18/24

Deadline

April 8 2024

Learn More

21

Days Left

AMLX

Amylyx Pharmaceuticals, Inc.

Deadline

April 9 2024

Class Period

11/11/22 - 11/8/23

Allegations

(i) defendants had overstated commercial prospects RELYVRIO, a dual UPRBax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the U.S.; (ii) patients were discontinuing treatment with RELYVRIO after six months; (iii) the rate at which new patients were starting treatment with RELYVRIO was decreasing; (iv) accordingly, defendants had also overstated RELYVRIO’s prescription rate; (v) defendants attempted to hide the foregoing negative trends from investors and the market by blocking analysts from viewing RELYVRIO’s prescription data; and (vi) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Class Period

11/11/22 - 11/8/23

Deadline

April 9 2024

Learn More

21

Days Left

XPOF

Xponential Fitness, Inc.

Deadline

April 9 2024

Class Period

7/26/21 - 12/7/23

Allegations

(a) Xponential had permanently closed at least 30 stores; (b) Xponential’s reported same-store sales (“SSS”) and average unit volume metrics had been misstated by excluding underperforming stores; (c) 8 out of 10 Xponential brands were losing money monthly; (d) over 50% of Xponential studios did not make a positive financial return; (e) over 60% of Xponential’s revenue was one-time and nonrecurring; (f) more than 100 of the Company’s franchises were for sale at a price that is at least 75% less than their initial cost; (g) Xponential had misled many of its franchisees into opening franchises by misrepresenting the financial profile and profitability of its studios, as well as the expected rate of return for new studio openings; (h) many Xponential franchisees were substantially in debt, suffering high attrition rates and running non-viable studios that had no realistic path to profitability; and (i) based on the foregoing, defendants lacked a reasonable factual basis for their positive statements about Xponential’s then-current business operations and future financial prospects.

Class Period

7/26/21 - 12/7/23

Deadline

April 9 2024

Learn More

27

Days Left

INMD

InMode Ltd.

Deadline

April 15 2024

Class Period

6/4/21 - 10/12/23

Allegations

(i) InMode heavily discounts almost every device it sells; (ii) demand for InMode’s products was driven by InMode’s willingness to discount its products; (iii) InMode violated U.S. Food and Drug Administration (“FDA”) regulations by engaging in off-label marketing and promoting products for treatment of indications for which they lack FDA approval; and (iv) InMode violated FDA regulations by failing to timely report injuries caused by its devices.

Class Period

6/4/21 - 10/12/23

Deadline

April 15 2024

Learn More

27

Days Left

AMPL

Amplitude, Inc.

Deadline

April 15 2024

Class Period

9/21/21 - 2/16/22

Allegations

(a) Amplitude’s land-and-expand strategy was years away from significantly accelerating revenues among its newer client cohorts; (b) the rapid acceleration in the Company’s 2Q21 results resulted from the ephemeral effects of the COVID-19 pandemic which had not continued by the start of the class period, as Amplitude clients were expanding at a slower pace; and (c) as a result of (a)-(b) above, Amplitude’s business, operations, financial results, and prospects were materially worse than represented to investors during the class period.

Class Period

9/21/21 - 2/16/22

Deadline

April 15 2024

Learn More

28

Days Left

NOVA

Sunnova Energy International Inc.

Deadline

April 16 2024

Class Period

2/25/20 - 12/7/23

Allegations

(i) Sunnova routinely engaged in predatory business practices against disadvantaged homeowners and communities, the same groups that Project Hestia, a new solar loan channel, was purportedly intended to benefit; (ii) the foregoing conduct subjected the company to a heightened risk of regulatory and/or governmental scrutiny, as well as significant reputational and/or financial harm; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

2/25/20 - 12/7/23

Deadline

April 16 2024

Learn More

34

Days Left

INOD

Innodata Inc.

Deadline

April 22 2024

Class Period

5/9/19 - 2/14/24

Allegations

(1) Innodata did not have a viable AI technology; (2) its Goldengate AI platform, the centerpiece of Innodata’s reported AI technology, is a rudimentary software developed by just a handful of employees; (3) it was not going to utilize AI to any significant degree for new Silicon Valley contracts; (4) it was not effectively investing in research and development for AI; and (5) based on the foregoing, defendants lacked a reasonable basis for their positive statements about Innodata’s AI business and development and related financial results, growth, and prospects.

Class Period

5/9/19 - 2/14/24

Deadline

April 22 2024

Learn More

34

Days Left

DKS

DICK's Sporting Goods, Inc.

Deadline

April 22 2024

Class Period

5/25/22 - 8/21/23

Allegations

a) demand for products in Dicks Sporting Good’s outdoor segment was slowing faster than defendants represented, resulting in excess inventory; (b) the “structural changes” that defendants repeatedly touted, including differentiated products, improved pricing technology, and more efficient clearance channels, did not allow the Company to manage its excess inventory without hurting the Company’s profitability; (c) the need to liquidate excess inventory, including in the outdoor segment, would have a materially negative effect on the Company’s profitability; and (d) as a result of (a)-(c) above, defendants’ statements about the Company’s business condition and prospects were materially false and misleading when made.

Class Period

5/25/22 - 8/21/23

Deadline

April 22 2024

Learn More

34

Days Left

FOXF

Fox Factory Holding Corp.

Deadline

April 22 2024

Class Period

5/6/21 - 11/2/23

Allegations

According to the filed complaint, defendants made misleading statements and omissions regarding the Company’s business, financial condition, and prospects, particularly with regard to demand for Fox Factory’s products and inventory levels. Specifically, the complaint alleges that on November 2, 2023, after the markets closed, Fox Factory filed a Form 8-K with the SEC, reporting that its net sales for the third quarter of fiscal year 2023 decreased 19.1% year-over-year due to "higher levels of inventory across various channels." In addition, Fox Factory cut its full-year sales guidance from between $1.67B and $1.70B to between $1.45B and $1.47B, citing continued inventory destocking in its Specialty Sports Group segment. On this news, the price of Fox Factory's common stock declined $22.60, or 37.34%, to close at $60.53 per share on November 3, 2023.

Class Period

5/6/21 - 11/2/23

Deadline

April 22 2024

Learn More

35

Days Left

LTRX

Lantronix, Inc.

Deadline

April 23 2024

Class Period

5/11/23 - 2/8/24

Allegations

(i) Lantronix overstated demand and/or its visibility into demand for its IoT products, network-enabled devices, excluding traditional computers like laptops and servers; (ii) Lantronix’s customers were reducing elevated levels of inventory of IoT products, thereby causing a general slowdown in the Company’s business; (iii) certain of Lantronix’s embedded IoT revenues expected from a customer design win were delayed to the next fiscal year; (iv) as a result of all the foregoing, Lantronix anticipated lower sales for its embedded IoT solutions for fiscal year 2024; (v) accordingly, Lantronix was unlikely to meet its own previously issued guidance for fiscal year 2024; and (vi) as a result, the Company’s public statements were materially false and/or misleading at all relevant times.

Class Period

5/11/23 - 2/8/24

Deadline

April 23 2024

Learn More

38

Days Left

PANW

Palo Alto Networks Inc.

Deadline

April 26 2024

Class Period

8/18/23 - 2/20/24

Allegations

(1) the Company’s consolidation and platformization initiatives were not driving increased market share to a significant degree; (2) the Company would need to ramp up platformization and free product offerings to entice customers to adopt more of their platforms; (3) the Company’s high growth in billings was not sustainable; (4) new AI offerings were not facilitating greater platformization and consolidation; and (5) based on the foregoing, defendants lacked a reasonable basis for their positive statements about customer demand, billings, and platformization, as well as related financial results, growth, and prospects.

Class Period

8/18/23 - 2/20/24

Deadline

April 26 2024

Learn More

41

Days Left

KIND

Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II

Deadline

April 29 2024

Class Period

7/6/21 - 11/8/22

Allegations

(a) Nextdoor’s financial results prior to the November 2021 merger with Khosla Ventures Acquisition Co. II, had been temporarily inflated by the ephemeral effects of the COVID-19 pandemic, which had pulled forward demand for Nextdoor’s platform and cannibalized future advertising revenue growth; (b) rather than being sustained, such growth trends had already begun reversing at the start of the class period; (c) Nextdoor’s total addressable market was materially smaller than the 312 million households represented to investors; (d) by the start of the class period, Nextdoor’s most important market – the U.S. market – was already substantially saturated, impairing the Company’s ability to monetize users and increase its average revenue per weekly active user, or U.S. weekly active user metrics; (e) as a result of (a)-(d) above, Nextdoor’s revenue guidance for fiscal year 2022 had no reasonable basis in fact and the Company was tracking tens of millions of dollars below the revenue trajectory provided to investors.

Class Period

7/6/21 - 11/8/22

Deadline

April 29 2024

Learn More

41

Days Left

PLCE

The Children's Place, Inc.

Deadline

April 29 2024

Class Period

3/16/23 - 2/8/24

Allegations

(1) the Company was engaged in aggressive promotions; (2) as a result, the Company’s inventory values were overstated; (3) the foregoing was reasonably likely to have an adverse impact on fiscal 2023 financial results; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Class Period

3/16/23 - 2/8/24

Deadline

April 29 2024

Learn More

41

Days Left

SNOW

Snowflake Inc.

Deadline

April 29 2024

Class Period

9/16/20 - 3/2/22

Allegations

(a) Snowflake had systematically oversold capacity to customers which created a misleading appearance of the demand for Snowflake’s products and services; (b) Snowflake had provided significant discounts to its customers prior to the Initial Public Offering (IPO) that temporarily boosted sales but would not be sustainable after the IPO and/or necessitate platform efficiency adjustments that negatively impacted client consumption and Snowflake’s revenue and profit margins; (c) as a result of (a)-(b) above, Snowflake’s customers were poised to roll over a material amount of unused credits (and thereby cannibalize future sales) at the end of their contracts’ terms or to refuse to renew their contracts at prior consumption levels or at all; (d) as a result (a)-(c) above, Snowflake’s product revenue and remaining performance obligations had been artificially inflated leading up to and during the class period; and (e) as a result of (a)-(d) above, defendants lacked a reasonable basis for their positive statements about Snowflake’s business, financials, and growth trajectory.

Class Period

9/16/20 - 3/2/22

Deadline

April 29 2024

Learn More

42

Days Left

VTYX

Ventyx Biosciences, Inc.

Deadline

April 30 2024

Class Period

10/21/21 - 11/6/23

Allegations

(i) VTX958, the Company's lead clinical product candidate, was less effective in treating psoriasis than defendants had led investors to believe; (ii) as a result, VTX958’s clinical and/or commercial prospects were overstated; (iii) accordingly, the Company had misrepresented its ability to develop and commercialize effective product candidates; (iv) Ventyx’s business prospects following the initial public offering were thus inflated; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

10/21/21 - 11/6/23

Deadline

April 30 2024

Learn More

49

Days Left

IRBT

iRobot Corporation

Deadline

May 7 2024

Class Period

8/5/22 - 1/26/24

Allegations

(i) the August 2022 merger of the Company and Amazon, would place Amazon in a sufficiently dominant position in the market for robot vacuum cleaners that U.S. and European antitrust regulators were unlikely to approve the merger; (ii) iRobot had conducted inadequate due diligence into the merger and/or ignored significant risks weighing against the likelihood of regulatory approval; (iii) as a result of all the foregoing, iRobot overstated the likelihood for successfully completing the merger; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

8/5/22 - 1/26/24

Deadline

May 7 2024

Learn More

55

Days Left

AVXL

Anavex Life Sciences Corporation

Deadline

May 13 2024

Class Period

2/1/22 - 1/1/24

Allegations

The complaint alleges that on December 2, 2022, AVXL announced positive topline results from its Phase 2b/3 ANAVEX®2-73-AD-004 clinical trial of oral ANAVEX®2-73 (blarcamesine) for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s disease (AD) and mild AD (collectively known as early AD). ANAVEX®2-73 met the primary endpoints ADAS-Cog1 and ADCS-ADL2 and key secondary endpoint CDR-SB3 with statistically significant results. An analyst questioned the Company’s claim noting “there are several key factors that point us to believe the data is provocative, but not yet compelling, given the choice of statistical analyses and other trial design/conduct ‘complexifiers’.” Additionally, a biotech journalist commented on AVXL’s findings stating “[w]hat sets Anavex apart from all the other biotechs on my radar screen is its habit of shifting the goalposts on clinical trials…Anavex announced “positive” outcomes from studies of its drug called blarcamesine — except the results were derived from efficacy endpoints that were not part of the original study designs.” Following this news, AVXL’s stock price fell by $2.47 per share, or approximately 20% to close at $9.58. Further on January 3, 2024, AVXL announced that results from its Phase 2/3 EXCELLENCE clinical trial for its candidate ANAVEX®2-73 in pediatric patients with Rett syndrome failed to show statistical significance towards its primary endpoints. Biotech analysts commented that “the negative study outcome was never in doubt…Anavex is a serial dissembler of clinical trial results.” Following this news, AVXL’s stock price fell by $3.26 per share, or approximately 35%.

Class Period

2/1/22 - 1/1/24

Deadline

May 13 2024

Learn More

56

Days Left

000

Next Bridge Hydrocarbons, Inc.

Deadline

May 14 2024

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Allegations

The complaint alleges that NBH filed a registration statement in connection with its spin-off from Meta Materials that contained false and/or materially misleading statements. The statements at issue concern the value of the Company’s oil and gas assets and NBH’s transactions with related parties. The complaint alleges that these false and/or materially misleading statements violated the Securities Act of 1933 and, consequently, damaged shareholders who received NBH shares in conjunction with the spin-off.

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Deadline

May 14 2024

Learn More

56

Days Left

INVZ

Innoviz Technologies Ltd.

Deadline

May 14 2024

Class Period

4/21/21 - 2/28/23

Allegations

(i) Innoviz had overstated the benefits that the Company was likely to derive from its purported contracts, partnerships, and/or collaborations with automotive companies; (ii) as a result, the Company was unlikely to achieve the level of profitability that defendants had represented to investors; (iii) accordingly, Innoviz had overstated its business and/or financial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Class Period

4/21/21 - 2/28/23

Deadline

May 14 2024

Learn More

56

Days Left

MMTLP

Next Bridge Hydrocarbons, Inc.

Deadline

May 14 2024

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Allegations

The complaint alleges that NBH filed a registration statement in connection with its spin-off from Meta Materials that contained false and/or materially misleading statements. The statements at issue concern the value of the Company’s oil and gas assets and NBH’s transactions with related parties. The complaint alleges that these false and/or materially misleading statements violated the Securities Act of 1933 and, consequently, damaged shareholders who received NBH shares in conjunction with the spin-off.

Class Period

This lawsuit is on behalf of all persons or entities that acquired shares of Next Bridge Hydrocarbons, Inc. in connection with the Company’s spin-off from Meta Materials, Inc. on or around December 14, 2022.

Deadline

May 14 2024

Learn More

News

Stay informed with the latest in settlement notices, case updates, publications, analyst reports, and more.
View All News

Learn More

Court Preliminarily Approves Settlement in In re AppHarvest, Inc. Securities Litigation
Update In re AppHarvest, Inc. Securities Litigation, Case No. 1:21-cv-07985-LJL: A settlement has been reached and was preliminarily approved on March 6, 2024. The settlement provides for the payment of $4.85 million to eligible class members.  Lead plaintiff Alan Narzissenfeld alleged violations of §§ 10(b) and 20(a) of the Securities Exchange Act of 1934 based...Read more

March 13, 2024

Learn More

Update in Expensify, Inc. Class Action
Wilhite v. Expensify, Inc., et al., 3:23-cv-01784-JR  is a lawsuit currently pending in the United States District Court for the District of Oregon. The action was filed on behalf of investors in Expensify, Inc. (NASDAQ: EXFY) who allegedly suffered losses due to securities fraud by the company. On March 11, 2024, Magistrate Jolie A. Russo...Read more

March 11, 2024

Learn More

L&K to Serve as Lead Counsel Representing ON Semiconductor Shareholders
On February 29, 2024, ON Semiconductor Corporation shareholder Jeffery S. Lew was appointed Lead Plaintiff in the action captioned Hubacek v. ON Semiconductor Corporation et al., Case No. 1:23-cv-1429-GBW, currently pending in the District Court for the District of Delaware.  The action concerns allegations of securities fraud against ON Semiconductor, and plaintiffs seek monetary recovery...Read more

March 6, 2024

Our World-Class Team

Levi & Korsinsky’s attorneys are admitted in over 40 state, federal, and appeal courts across the country. We have the specialized securities skills to achieve outstanding results, and our impressive variety of backgrounds means that we can go up against large companies of any kind and win. Our powerhouse attorneys have backgrounds in accounting, engineering, SEC enforcement, mathematics, regulatory analysis, international business, and prosecution, to name just a few. . .

View Attorneys